Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25755789PMCID PMC4348922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs in Cervical Cancer: Evidences for a miRNA Profile Deregulated by HPV and Its Impact on Radio-Resistance

  2014cited by this paper
• p16INK4a and ProEx C Immunostains Facilitate Differential Diagnosis of Hyperchromatic Crowded Groups in Liquid-Based Papanicolaou Tests with Menstrual Contamination

  2012cited by this paper
• Properties of the human Cdc45/Mcm2-7/GINS helicase complex and its action with DNA polymerase ε in rolling circle DNA synthesis

  2012cited by this paper
• Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma

  2011cited by this paper
• Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.

  2009cited by this paper
• Comparison of ProEx C with p16INK4a and Ki‐67 immunohistochemical staining of cell blocks prepared from residual liquid‐based cervicovaginal material

  2008influential reference
• MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India

  2007influential reference
• Validation of a novel immunocytochemical assay for topoisomerase II‐α and minichromosome maintenance protein 2 expression in cervical cytology

  2006influential reference
• Detection of cervical high‐grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx™ C)

  2006cited by this paper
• p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer

  2005cited by this paper
• Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence.

  2005cited by this paper
• A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities

  2005cited by this paper
• Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

  2005influential reference
• Control of DNA replication and its potential clinical exploitation

  2005cited by this paper
• Tissue Microarrays Identification of Cervical Cancer Markers by cDNA and Updated

  2003cited by this paper
• Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray.

  2003influential reference
• Papillomaviruses and cancer: from basic studies to clinical application

  2002cited by this paper
• Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

  2001cited by this paper
• The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note.

  2001influential reference
• Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

  2000cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999cited by this paper
• MCM proteins: evolution, properties, and role in DNA replication.

  1998cited by this paper
• Improved cervical smear assessment using antibodies against proteins that regulate DNA replication.

  1998cited by this paper

• Thymopoietin-α, -β, and -γ Isoforms Increased Expression in Cervical Cancer Cells

  2025cites this paper
• Alcohol consumption and DNA methylation: an epigenome-wide association study within the French E3N cohort

  2025cites this paper
• RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions.

  2024cites this paper
• Screening and Identification of Prognostic Biomarkers of Cervical Cancer Based on Bioinformatics Analysis

  2024cites this paper
• Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer

  2023cites this paper
• Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics

  2022cites this paper
• Chlamydia pneumoniae Interferes with Macrophage Differentiation and Cell Cycle Regulation to Promote Its Replication

  2022cites this paper
• Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer

  2021cites this paper
• DETECTION OF CERVICAL LESIONS AND CANCER IN AIR-DRIED CYTOLOGICAL SMEARS BY COMBINED ANALYSIS OF MRNA AND MIRNA EXPRESSION LEVELS.

  2021cites this paper
• MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2

  2021cites this paper
• Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer

  2021cites this paper
• Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer

  2021cites this paper
• Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis

  2020cites this paper
• Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection

  2020cites this paper
• A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer

  2020influential citation
• MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer

  2020cites this paper
• Progress in immunocytochemical staining for cervical cancer screening

  2019cites this paper
• Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development

  2019influential citation
• Cancer molecular markers: A guide to cancer detection and management.

  2018cites this paper
• Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women

  2018cites this paper
• Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy

  2018cites this paper
• An interaction network driven approach for identifying biomarkers for progressing cervical intraepithelial neoplasia

  2018cites this paper
• MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation.

  2017cites this paper
• The importance of immunocytochemistry in the detection of high-grade cervical lesions.

  2017cites this paper
• ROLE OF TUMOR MARKERS IN CERVICAL CARCINOGENESIS

  year unknowncites this paper